J. Kevin Buchi

In his current position since 2013. He previously was corporate VP of Global Branded Products for Teva Pharmaceutical Industries Ltd. and CEO of Cephalon Inc. He is a director of Benitec Biopharma Ltd., a biotechnology company headquartered in Australia.

  • 2017 First Quarter

Added to: Impax Laboratories Inc. - Hayward, CA

Impax Laboratories is a specialty pharmaceutical company. Revenues are $908 million.